At a glance
ClinicalIndex Comparison RecordN/ACompleted· 33 enrolled
Drug / intervention
Ha-330 Hemoperfusion Filter Hemodialysis +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison Between HA330 Hemoperfusion Filter Hemodialysis and Conventional High-Flux Filter Hemodialysis in Reducing Inflammatory Mediators in Renal Dysfunction Due to Sepsis
In Brief
A clinical study evaluating Ha-330 Hemoperfusion Filter Hemodialysis and Conventional Hemodialysis for Renal Dysfunction and 2 related conditions. Completed, enrolled 33 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the effectiveness between conventional hemodialysis and hemodialysis using hemoperfusion adsorbents in renal dysfunction caused by sepsis
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Dysfunction, Sepsis, Hemodialysis
CountriesIndonesia
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartJun 2023
First PostedJul 2023
Primary CompletionDec 2023
Study CompletionMar 2024
TodayJul 2026
First PostedJul 12, 2023
Enrollment StartJun 16, 2023
Primary CompletionDec 31, 2023
Study CompletionMar 31, 2024
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 3.0 years ago
Interventions
Ha-330 Hemoperfusion Filter Hemodialysisdevice
a total of 4 hours therapy, 3 times a week. Each therapy should be two days apart
Conventional Hemodialysisdevice
a total of 4 hours therapy, 3 times a week. Each therapy should be two days apart